The Effect of Superficial EMG Biofeedback Training on Muscle Activation, Proprioception, Reaction Time and Upper Extremity Functions in Patients with Chronic Neck Pain: a Single-Blind Randomized Controlled Trial
Launched by PERVIN YEŞILOĞLU · Mar 20, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presentation to the clinic with neck pain for at least 3 months due to at least one of the following causes: facet joint dysfunction, cervical disc lesions, myofascial pain syndrome, cervical spondylosis, mechanical neck pain,
- • To be between the ages of 18-65,
- • To cooperate with the evaluation parameters to be applied in the study,
- • Volunteering to participate in the study,
- • Not having received physical therapy for neck pain before,
- Exclusion Criteria:
- • Over 65 years of age,
- • Problems in perceiving verbal commands,
- • Having benefited from physiotherapy and/or another treatment method for neck pain within the last 1 year,
- • Undergoing any operation related to pathologies of the neck region,
- • To have undergone upper extremity surgery,
- • Presence of neurological symptoms,
- • Presence of comorbidities affecting upper extremity and hand functions (carpal tunnel syndrome, trigger finger, impingement syndrome, thoracic outlet syndrome, lateral and medial epicondylitis, hand osteoarthritis),
- • Pregnancy.
About Pervin Yeşiloğlu
Pervin Yeşiloğlu is a distinguished clinical trial sponsor known for her commitment to advancing medical research and improving patient outcomes. With a robust background in clinical operations and regulatory compliance, she leads initiatives that prioritize innovation and ethical standards in clinical trials. Under her guidance, the organization fosters collaborative partnerships with healthcare professionals and research institutions, ensuring the efficient execution of studies across various therapeutic areas. Pervin's strategic vision and dedication to scientific integrity position her as a pivotal figure in the landscape of clinical research, driving progress and fostering trust in the development of new therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Izmir, Balcova, Turkey
Patients applied
Trial Officials
Pervin Yeşiloğlu, Research Assisstant
Principal Investigator
Yuzuncu Yıl University
Ayşe M Tat, Assoc. Prof.
Study Chair
Yuzuncu Yıl University
Murat Toprak, Assoc. Prof.
Study Chair
Van Yüzüncü Yıl Üniversitesi Tıp Fakültesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported